Robinswood Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-9
Closed -$104 – 414
2025
Q3
$104 Hold
9
– – ﹤0.01% 379
2025
Q2
$94 Sell
9
-3
-25% -$31 ﹤0.01% 386
2025
Q1
$191 Hold
12
– – ﹤0.01% 381
2024
Q4
$190 Hold
12
– – ﹤0.01% 335
2024
Q3
$243 Buy
12
+3
+33% +$62 ﹤0.01% 339
2024
Q2
$201 Hold
9
– – ﹤0.01% 346
2024
Q1
$180 Hold
9
– – ﹤0.01% 239
2023
Q4
$140 Hold
9
– – ﹤0.01% 237
2023
Q3
$169 Hold
9
– – ﹤0.01% 238
2023
Q2
$202 Buy
+9
New +$196 ﹤0.01% 217

Other funds holding OGN

Robinswood Financial's OGN Position: Q4 2025 in Review

Robinswood Financial sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 9 shares — an estimated $104 sold.

Robinswood Financial first reported a position in OGN in Q2 2023 and held it in 10 quarters. The position peaked at $243 in Q3 2024. 635 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Robinswood Financial reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Robinswood Financial sold 9 Organon & Co shares in Q4 2025, an estimated $104.
  • Robinswood Financial first reported a position in Organon & Co in Q2 2023 and held it in 10 quarters.
  • Robinswood Financial's Organon & Co position peaked at $243 in Q3 2024.
  • 635 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Robinswood Financial's 13F filing for Q4 2025, filed 14 Jul 2026.